APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Pathology Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Molecular Pathology Services Market Analysis and Forecast 2026-2032

1 May 2026243 pages

Choose your research edition.

Industry ResearchMolecular Pathology Services Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Pathology Services Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Molecular Pathology Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Pathology Services Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Pathology Services Market Analysis and Forecast 2026-2032243 pages · $4,950 USD

Market perspective

The global Molecular Pathology Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Molecular Pathology Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Molecular Pathology Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Molecular Pathology Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Molecular Pathology Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Molecular Pathology Services include Quest Diagnostics, Labcorp, Sonic Healthcare, NeoGenomics, Foundation Medicine, Caris Life Sciences, Tempus, Guardant Health and Exact Sciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Molecular Pathology Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Molecular Pathology Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Molecular Pathology Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Molecular Pathology Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Molecular Pathology Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Molecular Pathology Services revenue, projected growth trends, production technology, application and end-user industry.

Molecular Pathology Services Segment by Company

Quest Diagnostics

Labcorp

Sonic Healthcare

NeoGenomics

Foundation Medicine

Caris Life Sciences

Tempus

Guardant Health

Exact Sciences

Eurofins

Unilabs

Molecular Pathology Services Segment by Type

Solid Tumor Molecular Pathology Services

Hematologic Malignancy Molecular Pathology Services

Hereditary Disease Molecular Pathology Services

Infectious Disease Molecular Testing Services

Rare Disease Molecular Pathology Services

Others

Molecular Pathology Services Segment by Application

Hospitals and Medical Centers

Independent Clinical Laboratories

Academic and Research Institutes

Biopharmaceutical Companies

Others

Molecular Pathology Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Pathology Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Pathology Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Pathology Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Molecular Pathology Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Molecular Pathology Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Pathology Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Molecular Pathology Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Solid Tumor Molecular Pathology Services Major Player Table 3. Hematologic Malignancy Molecular Pathology Services Major Player Table 4. Hereditary Disease Molecular Pathology Services Major Player Table 5. Infectious Disease Molecular Testing Services Major Player Table 6. Rare Disease Molecular Pathology Services Major Player Table 7. Others Major Player Table 8. Global Molecular Pathology Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospitals and Medical Centers Major Player Table 10. Independent Clinical Laboratories Major Player Table 11. Academic and Research Institutes Major Player Table 12. Biopharmaceutical Companies Major Player Table 13. Others Major Player Table 14. Molecular Pathology Services Industry Trends Table 15. Molecular Pathology Services Industry Drivers Table 16. Molecular Pathology Services Industry Opportunities and Challenges Table 17. Molecular Pathology Services Industry Restraints Table 18. Global Molecular Pathology Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 19. Global Molecular Pathology Services Market Size by Region (2021-2026) & (US$ Million) Table 20. Global Molecular Pathology Services Market Share by Region (2021-2026) Table 21. Global Molecular Pathology Services Market Size by Region (2027-2032) & (US$ Million) Table 22. Global Molecular Pathology Services Market Share by Region (2027-2032) Table 23. Global Molecular Pathology Services Revenue by Players (US$ Million) & (2021-2026) Table 24. Global Molecular Pathology Services Revenue Market Share by Players (2021-2026) Table 25. Global Molecular Pathology Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 26. Global Molecular Pathology Services Key Players Headquarters & Area Served Table 27. Global Molecular Pathology Services Players, Product Type & Application Table 28. Global Molecular Pathology Services Players Establishment Date Table 29. Global Players Market Concentration Ratio (CR5 and HHI) Table 30. Global Molecular Pathology Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 31. Global Molecular Pathology Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Molecular Pathology Services Revenue by Type (2021-2026) & (US$ Million) Table 33. Global Molecular Pathology Services Revenue by Type (2027-2032) & (US$ Million) Table 34. Global Molecular Pathology Services Revenue Market Share by Type (2021-2026) Table 35. Global Molecular Pathology Services Revenue Market Share by Type (2027-2032) Table 36. Global Molecular Pathology Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Molecular Pathology Services Revenue by Application (2021-2026) & (US$ Million) Table 38. Global Molecular Pathology Services Revenue by Application (2027-2032) & (US$ Million) Table 39. Global Molecular Pathology Services Revenue Market Share by Application (2021-2026) Table 40. Global Molecular Pathology Services Revenue Market Share by Application (2027-2032) Table 41. Quest Diagnostics Company Information Table 42. Quest Diagnostics Business Overview Table 43. Quest Diagnostics Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Quest Diagnostics Molecular Pathology Services Product Portfolio Table 45. Quest Diagnostics Recent Development Table 46. Labcorp Company Information Table 47. Labcorp Business Overview Table 48. Labcorp Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Labcorp Molecular Pathology Services Product Portfolio Table 50. Labcorp Recent Development Table 51. Sonic Healthcare Company Information Table 52. Sonic Healthcare Business Overview Table 53. Sonic Healthcare Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Sonic Healthcare Molecular Pathology Services Product Portfolio Table 55. Sonic Healthcare Recent Development Table 56. NeoGenomics Company Information Table 57. NeoGenomics Business Overview Table 58. NeoGenomics Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. NeoGenomics Molecular Pathology Services Product Portfolio Table 60. NeoGenomics Recent Development Table 61. Foundation Medicine Company Information Table 62. Foundation Medicine Business Overview Table 63. Foundation Medicine Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Foundation Medicine Molecular Pathology Services Product Portfolio Table 65. Foundation Medicine Recent Development Table 66. Caris Life Sciences Company Information Table 67. Caris Life Sciences Business Overview Table 68. Caris Life Sciences Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Caris Life Sciences Molecular Pathology Services Product Portfolio Table 70. Caris Life Sciences Recent Development Table 71. Tempus Company Information Table 72. Tempus Business Overview Table 73. Tempus Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Tempus Molecular Pathology Services Product Portfolio Table 75. Tempus Recent Development Table 76. Guardant Health Company Information Table 77. Guardant Health Business Overview Table 78. Guardant Health Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Guardant Health Molecular Pathology Services Product Portfolio Table 80. Guardant Health Recent Development Table 81. Exact Sciences Company Information Table 82. Exact Sciences Business Overview Table 83. Exact Sciences Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Exact Sciences Molecular Pathology Services Product Portfolio Table 85. Exact Sciences Recent Development Table 86. Eurofins Company Information Table 87. Eurofins Business Overview Table 88. Eurofins Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Eurofins Molecular Pathology Services Product Portfolio Table 90. Eurofins Recent Development Table 91. Unilabs Company Information Table 92. Unilabs Business Overview Table 93. Unilabs Molecular Pathology Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Unilabs Molecular Pathology Services Product Portfolio Table 95. Unilabs Recent Development Table 96. North America Molecular Pathology Services Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Molecular Pathology Services Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Molecular Pathology Services Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Molecular Pathology Services Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Molecular Pathology Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Molecular Pathology Services Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Molecular Pathology Services Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Molecular Pathology Services Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Molecular Pathology Services Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Molecular Pathology Services Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Molecular Pathology Services Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Molecular Pathology Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Molecular Pathology Services Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Molecular Pathology Services Revenue by Country (US$ Million) & (2027-2032) Table 110. China Molecular Pathology Services Revenue by Type (2021-2026) & (US$ Million) Table 111. China Molecular Pathology Services Revenue by Type (2027-2032) & (US$ Million) Table 112. China Molecular Pathology Services Revenue by Application (2021-2026) & (US$ Million) Table 113. China Molecular Pathology Services Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Molecular Pathology Services Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Molecular Pathology Services Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Molecular Pathology Services Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Molecular Pathology Services Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Molecular Pathology Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Molecular Pathology Services Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Molecular Pathology Services Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Molecular Pathology Services Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Molecular Pathology Services Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Molecular Pathology Services Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Molecular Pathology Services Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Molecular Pathology Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Molecular Pathology Services Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Molecular Pathology Services Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Molecular Pathology Services Image Figure 2. Global Molecular Pathology Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Pathology Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Solid Tumor Molecular Pathology Services Image Figure 5. Hematologic Malignancy Molecular Pathology Services Image Figure 6. Hereditary Disease Molecular Pathology Services Image Figure 7. Infectious Disease Molecular Testing Services Image Figure 8. Rare Disease Molecular Pathology Services Image Figure 9. Others Image Figure 10. Global Molecular Pathology Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Molecular Pathology Services Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospitals and Medical Centers Image Figure 13. Independent Clinical Laboratories Image Figure 14. Academic and Research Institutes Image Figure 15. Biopharmaceutical Companies Image Figure 16. Others Image Figure 17. Global Molecular Pathology Services Market Size (US$ Million) & (2021-2032) Figure 18. Global Molecular Pathology Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Molecular Pathology Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global Molecular Pathology Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Molecular Pathology Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Molecular Pathology Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Molecular Pathology Services Revenue Market Share by Type (2021-2032) Figure 25. Global Molecular Pathology Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Molecular Pathology Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 27. Global Molecular Pathology Services Revenue Market Share by Application (2021-2032) Figure 28. North America Molecular Pathology Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. North America Molecular Pathology Services Revenue Share by Type (2021-2032) Figure 30. North America Molecular Pathology Services Revenue Share by Application (2021-2032) Figure 31. North America Molecular Pathology Services Revenue Share by Country (2021-2032) Figure 32. United States Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Canada Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Mexico Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Europe Molecular Pathology Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 36. Europe Molecular Pathology Services Revenue Share by Type (2021-2032) Figure 37. Europe Molecular Pathology Services Revenue Share by Application (2021-2032) Figure 38. Europe Molecular Pathology Services Revenue Share by Country (2021-2032) Figure 39. Germany Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. France Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. U.K. Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Italy Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Spain Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Russia Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Netherlands Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Nordic Countries Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. China Molecular Pathology Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. China Molecular Pathology Services Revenue Share by Type (2021-2032) Figure 49. China Molecular Pathology Services Revenue Share by Application (2021-2032) Figure 50. Asia Molecular Pathology Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. Asia Molecular Pathology Services Revenue Share by Type (2021-2032) Figure 52. Asia Molecular Pathology Services Revenue Share by Application (2021-2032) Figure 53. Asia Molecular Pathology Services Revenue Share by Region (2021-2032) Figure 54. Japan Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. South Korea Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. India Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Australia Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Taiwan Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Southeast Asia Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. SAMEA Molecular Pathology Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 61. SAMEA Molecular Pathology Services Revenue Share by Type (2021-2032) Figure 62. SAMEA Molecular Pathology Services Revenue Share by Application (2021-2032) Figure 63. SAMEA Molecular Pathology Services Revenue Share by Country (2021-2032) Figure 64. Brazil Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Argentina Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Chile Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Colombia Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Peru Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Saudi Arabia Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Israel Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. UAE Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Turkey Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Iran Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Egypt Molecular Pathology Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Tumor Molecular Pathology Services
  • Hematologic Malignancy Molecular Pathology Services
  • Hereditary Disease Molecular Pathology Services
  • Infectious Disease Molecular Testing Services
  • Rare Disease Molecular Pathology Services
  • Others
Applications
  • Hospitals and Medical Centers
  • Independent Clinical Laboratories
  • Academic and Research Institutes
  • Biopharmaceutical Companies
  • Others
Companies covered
  • Quest Diagnostics
  • Labcorp
  • Sonic Healthcare
  • NeoGenomics
  • Foundation Medicine
  • Caris Life Sciences
  • Tempus
  • Guardant Health
  • Exact Sciences
  • Eurofins
  • Unilabs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Molecular Pathology Services Market by Type
  3. 1.2.1 Global Molecular Pathology Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Solid Tumor Molecular Pathology Services
  5. 1.2.3 Hematologic Malignancy Molecular Pathology Services
  6. 1.2.4 Hereditary Disease Molecular Pathology Services
  7. 1.2.5 Infectious Disease Molecular Testing Services
  8. 1.2.6 Rare Disease Molecular Pathology Services
  9. 1.2.7 Others
  10. 1.3 Molecular Pathology Services Market by Application
  11. 1.3.1 Global Molecular Pathology Services Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospitals and Medical Centers
  13. 1.3.3 Independent Clinical Laboratories
  14. 1.3.4 Academic and Research Institutes
  15. 1.3.5 Biopharmaceutical Companies
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Molecular Pathology Services Market Dynamics
  1. 2.1 Molecular Pathology Services Industry Trends
  2. 2.2 Molecular Pathology Services Industry Drivers
  3. 2.3 Molecular Pathology Services Industry Opportunities and Challenges
  4. 2.4 Molecular Pathology Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Molecular Pathology Services Market Perspective (2021-2032)
  2. 3.2 Global Molecular Pathology Services Growth Trends by Region
  3. 3.2.1 Global Molecular Pathology Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Molecular Pathology Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Molecular Pathology Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Molecular Pathology Services Revenue by Players
  2. 4.1.1 Global Molecular Pathology Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Molecular Pathology Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Molecular Pathology Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Molecular Pathology Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Molecular Pathology Services Key Players Headquarters & Area Served
  7. 4.4 Global Molecular Pathology Services Players, Product Type & Application
  8. 4.5 Global Molecular Pathology Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Molecular Pathology Services Market CR5 and HHI
  11. 4.6.3 2025 Molecular Pathology Services Tier 1, Tier 2, and Tier 3
5 Molecular Pathology Services Market Size by Type
  1. 5.1 Global Molecular Pathology Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Molecular Pathology Services Revenue by Type (2021-2032)
  3. 5.3 Global Molecular Pathology Services Revenue Market Share by Type (2021-2032)
6 Molecular Pathology Services Market Size by Application
  1. 6.1 Global Molecular Pathology Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Molecular Pathology Services Revenue by Application (2021-2032)
  3. 6.3 Global Molecular Pathology Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Quest Diagnostics
  2. 7.1.1 Quest Diagnostics Company Information
  3. 7.1.2 Quest Diagnostics Business Overview
  4. 7.1.3 Quest Diagnostics Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Quest Diagnostics Molecular Pathology Services Product Portfolio
  6. 7.1.5 Quest Diagnostics Recent Developments
  7. 7.2 Labcorp
  8. 7.2.1 Labcorp Company Information
  9. 7.2.2 Labcorp Business Overview
  10. 7.2.3 Labcorp Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Labcorp Molecular Pathology Services Product Portfolio
  12. 7.2.5 Labcorp Recent Developments
  13. 7.3 Sonic Healthcare
  14. 7.3.1 Sonic Healthcare Company Information
  15. 7.3.2 Sonic Healthcare Business Overview
  16. 7.3.3 Sonic Healthcare Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sonic Healthcare Molecular Pathology Services Product Portfolio
  18. 7.3.5 Sonic Healthcare Recent Developments
  19. 7.4 NeoGenomics
  20. 7.4.1 NeoGenomics Company Information
  21. 7.4.2 NeoGenomics Business Overview
  22. 7.4.3 NeoGenomics Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 NeoGenomics Molecular Pathology Services Product Portfolio
  24. 7.4.5 NeoGenomics Recent Developments
  25. 7.5 Foundation Medicine
  26. 7.5.1 Foundation Medicine Company Information
  27. 7.5.2 Foundation Medicine Business Overview
  28. 7.5.3 Foundation Medicine Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Foundation Medicine Molecular Pathology Services Product Portfolio
  30. 7.5.5 Foundation Medicine Recent Developments
  31. 7.6 Caris Life Sciences
  32. 7.6.1 Caris Life Sciences Company Information
  33. 7.6.2 Caris Life Sciences Business Overview
  34. 7.6.3 Caris Life Sciences Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Caris Life Sciences Molecular Pathology Services Product Portfolio
  36. 7.6.5 Caris Life Sciences Recent Developments
  37. 7.7 Tempus
  38. 7.7.1 Tempus Company Information
  39. 7.7.2 Tempus Business Overview
  40. 7.7.3 Tempus Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Tempus Molecular Pathology Services Product Portfolio
  42. 7.7.5 Tempus Recent Developments
  43. 7.8 Guardant Health
  44. 7.8.1 Guardant Health Company Information
  45. 7.8.2 Guardant Health Business Overview
  46. 7.8.3 Guardant Health Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Guardant Health Molecular Pathology Services Product Portfolio
  48. 7.8.5 Guardant Health Recent Developments
  49. 7.9 Exact Sciences
  50. 7.9.1 Exact Sciences Company Information
  51. 7.9.2 Exact Sciences Business Overview
  52. 7.9.3 Exact Sciences Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Exact Sciences Molecular Pathology Services Product Portfolio
  54. 7.9.5 Exact Sciences Recent Developments
  55. 7.10 Eurofins
  56. 7.10.1 Eurofins Company Information
  57. 7.10.2 Eurofins Business Overview
  58. 7.10.3 Eurofins Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Eurofins Molecular Pathology Services Product Portfolio
  60. 7.10.5 Eurofins Recent Developments
  61. 7.11 Unilabs
  62. 7.11.1 Unilabs Company Information
  63. 7.11.2 Unilabs Business Overview
  64. 7.11.3 Unilabs Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Unilabs Molecular Pathology Services Product Portfolio
  66. 7.11.5 Unilabs Recent Developments
8 North America
  1. 8.1 North America Molecular Pathology Services Revenue (2021-2032)
  2. 8.2 North America Molecular Pathology Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Molecular Pathology Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Molecular Pathology Services Revenue by Type (2027-2032)
  5. 8.3 North America Molecular Pathology Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Molecular Pathology Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Molecular Pathology Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Molecular Pathology Services Revenue by Application (2027-2032)
  9. 8.5 North America Molecular Pathology Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Molecular Pathology Services Revenue by Country
  11. 8.6.1 North America Molecular Pathology Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Molecular Pathology Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Molecular Pathology Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Molecular Pathology Services Revenue (2021-2032)
  2. 9.2 Europe Molecular Pathology Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Molecular Pathology Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Molecular Pathology Services Revenue by Type (2027-2032)
  5. 9.3 Europe Molecular Pathology Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Molecular Pathology Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Molecular Pathology Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Molecular Pathology Services Revenue by Application (2027-2032)
  9. 9.5 Europe Molecular Pathology Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Molecular Pathology Services Revenue by Country
  11. 9.6.1 Europe Molecular Pathology Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Molecular Pathology Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Molecular Pathology Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Molecular Pathology Services Revenue (2021-2032)
  2. 10.2 China Molecular Pathology Services Revenue by Type (2021-2032)
  3. 10.2.1 China Molecular Pathology Services Revenue by Type (2021-2026)
  4. 10.2.2 China Molecular Pathology Services Revenue by Type (2027-2032)
  5. 10.3 China Molecular Pathology Services Revenue Share by Type (2021-2032)
  6. 10.4 China Molecular Pathology Services Revenue by Application (2021-2032)
  7. 10.4.1 China Molecular Pathology Services Revenue by Application (2021-2026)
  8. 10.4.2 China Molecular Pathology Services Revenue by Application (2027-2032)
  9. 10.5 China Molecular Pathology Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Molecular Pathology Services Revenue (2021-2032)
  2. 11.2 Asia Molecular Pathology Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Molecular Pathology Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Molecular Pathology Services Revenue by Type (2027-2032)
  5. 11.3 Asia Molecular Pathology Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Molecular Pathology Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Molecular Pathology Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Molecular Pathology Services Revenue by Application (2027-2032)
  9. 11.5 Asia Molecular Pathology Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Molecular Pathology Services Revenue by Country
  11. 11.6.1 Asia Molecular Pathology Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Molecular Pathology Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Molecular Pathology Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Molecular Pathology Services Revenue (2021-2032)
  2. 12.2 SAMEA Molecular Pathology Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Molecular Pathology Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Molecular Pathology Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Molecular Pathology Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Molecular Pathology Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Molecular Pathology Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Molecular Pathology Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Molecular Pathology Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Molecular Pathology Services Revenue by Country
  11. 12.6.1 SAMEA Molecular Pathology Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Molecular Pathology Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Molecular Pathology Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst